• Immunovant, Inc. (NASDAQ:IMVT) Receives Average Recommendation of "Moderate Buy" from Brokerages

    Source: Buzz FX / 13 Jan 2025 03:50:15   America/Chicago


    Immunovant, Inc. (NASDAQ:IMVT) Receives Average Recommendation of "Moderate Buy" from Brokerages Written by MarketBeat January 13, 2025 Share Link copied to clipboard. Shares of Immunovant, Inc. ( NASDAQ:IMVT - Get Free Report ) have been g
    Read more...
Share on,